| Name | N-(4-acetylphenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide |
|---|---|
| Synonyms |
MRS 1706
Tocris-1584 MRS-1706 |
| Description | MRS-1706 is a potent and selective A(2B) adenosine receptor antagonist with a Ki value of 1.39 nM. |
|---|---|
| Related Catalog | |
| Target |
IC50: 1.39 nM (A(2B) human adenosine receptor)[1]. |
| In Vitro | MRS-1706 is a selective adenosine A2B receptor inverse agonist with Ki values of 1.39, 157, 112, and 230 nM for human A2B, A1, A2A, and A3 receptors, respectively[1]. Pretreatment with ZM241385 (A2A-Ado receptor antagonist) alone or in combination with MRS-1706 (A2B-Ado receptor antagonist) results in a pure constriction upon adenosine[2]. |
| References |
| Molecular Formula | C27H29N5O5 |
|---|---|
| Molecular Weight | 503.55000 |
| Exact Mass | 503.21700 |
| PSA | 128.08000 |
| LogP | 3.66640 |
| Storage condition | 2-8℃ |